As of 4:00pm ET
| +0.25 / +18.12%|
The 6 analysts offering 12-month price forecasts for Novavax Inc have a median target of 1.50, with a high estimate of 12.00 and a low estimate of 1.50. The median estimate represents a -7.98% decrease from the last price of 1.63.
The current consensus among 8 polled investment analysts is to Hold stock in Novavax Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.